Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

UGT1A polymorphisms as genetic biomarkers for hepatocellular carcinoma risk in Caucasian population
Elena De Mattia, Erika Cecchin, Jerry Polesel, et al.
Liver International (2017) Vol. 37, Iss. 9, pp. 1345-1353
Closed Access | Times Cited: 21

Showing 21 citing articles:

The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms
Robyn Meech, Dong Hu, Ross A. McKinnon, et al.
Physiological Reviews (2019) Vol. 99, Iss. 2, pp. 1153-1222
Open Access | Times Cited: 275
New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma
Michele Dal Bo, Elena De Mattia, Lorena Baboçi, et al.
Drug Resistance Updates (2020) Vol. 51, pp. 100702-100702
Open Access | Times Cited: 78
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
Elena De Mattia, Erika Cecchin, Michela Guardascione, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 29, pp. 3870-3896
Open Access | Times Cited: 75
Single-cell analysis reveals the intra-tumor heterogeneity and identifies MLXIPL as a biomarker in the cellular trajectory of hepatocellular carcinoma
Xiao Dong, Fan Wang, Chuan Liu, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 33
SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand
Raffaele Palmirotta, Claudia Carella, Erica Silvestris, et al.
Oncotarget (2018) Vol. 9, Iss. 38, pp. 25355-25382
Open Access | Times Cited: 42
Preoperative serum ctDNA predicts early hepatocellular carcinoma recurrence and response to systemic therapies
Yizhen Fu, Zhenyun Yang, Zili Hu, et al.
Hepatology International (2022) Vol. 16, Iss. 4, pp. 868-878
Closed Access | Times Cited: 20
The relationship between UGT1A1 gene & various diseases and prevention strategies
Dan Liu, Qi Yu, Qing Ning, et al.
Drug Metabolism Reviews (2021) Vol. 54, Iss. 1, pp. 1-21
Closed Access | Times Cited: 26
Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients’ Management and Therapy Outcomes
Silvia Mezzalira, Elena De Mattia, Michela Guardascione, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5498-5498
Open Access | Times Cited: 29
Genetic biomarkers for hepatocellular cancer risk in a caucasian population
Elena De Mattia, Erika Cecchin, Jerry Polesel, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 36, pp. 6674-6684
Open Access | Times Cited: 25
Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker
Chuanfei Li, Di Zhou, Xiaoling Jiang, et al.
Gene (2019) Vol. 698, pp. 9-18
Closed Access | Times Cited: 19
Proteomic analysis of mouse liver lesions at all three stages of Echinococcus granulosus infection
Nan Jiang, Chen Yang, Teng Li, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 12, pp. e0012659-e0012659
Open Access | Times Cited: 1
Insomnia affects the levels of plasma bilirubin and protein metabolism: an observational study and GWGEIS in UK Biobank cohort
Xiaomeng Chu, Li Liu, Jing Ye, et al.
Sleep Medicine (2021) Vol. 85, pp. 184-190
Closed Access | Times Cited: 7
Pharmacogenetic Score Predicts Overall Survival, Progression-Free Survival and Platinum Sensitivity in Ovarian Cancer
Sara Gagno, Michele Bartoletti, Chiara Romualdi, et al.
Pharmacogenomics (2020) Vol. 21, Iss. 14, pp. 995-1010
Open Access | Times Cited: 6
Genetic variants of UDP‐glucuronosyltransferase 1A genes are associated with disease presentation and outcome in primary sclerosing cholangitis
Tobias J. Weismüller, Taotao Zhou, Sandra Kalthoff, et al.
Liver International (2020) Vol. 40, Iss. 7, pp. 1645-1654
Open Access | Times Cited: 5
Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma
Jun Matsumoto, Anzu Nishimoto, Shogo Watari, et al.
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 8, pp. 1779-1790
Closed Access | Times Cited: 3
Transcriptome Profiling of A549 Xenografts of Nonsmall-cell Lung Cancer Treated with Qing-Re-Huo-Xue Formula
Zexi Lv, Xiqun Chen, Kai Yang, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 2
UGT1As and predisposition to liver cancer: Still important, more elusive
Pascal Pineau
Liver International (2017) Vol. 37, Iss. 9, pp. 1284-1286
Open Access | Times Cited: 1
Predicting drug response and toxicity in metastatic colorectal cancer: the role of germline markers
Alessia Bignucolo, Lucia Scarabel, Giuseppe Toffoli, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 6, pp. 689-713
Closed Access | Times Cited: 1
Association of gallstone and polymorphisms of UGT1A1*27 and UGT1A1*28 in patients with hepatitis B virus-related liver failure
Haiyan Zhuo, Jinhai Fan, Bifeng Zhang, et al.
Open Medicine (2022) Vol. 17, Iss. 1, pp. 1455-1465
Open Access | Times Cited: 1
Molecular Signature Of Subtypes Of Renal Cell Carcinomas And Immunotherapy Strategy
Jianing Guo, Xi Yu, Bin He, et al.
Research Square (Research Square) (2022)
Open Access
Molecular Signature of Subtypes of Renal cell carcinomas and Immunotherapy strategy
Jianing Guo, Xiaofei Lv, Bin He, et al.
Research Square (Research Square) (2021)
Open Access
Page 1

Scroll to top